Conversations on Cancer Program, Pazdur+25—Celebrating a Silver FDA Anniversary
Join previous FDA Commissioners and the FDA Oncology Center of Excellence, in recognizing a quarter century of federal government service by OCE Center Direc…
Join previous FDA Commissioners and the FDA Oncology Center of Excellence, in recognizing a quarter century of federal government service by OCE Center Direc…
Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.
In a study presented at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, held October 23–25, researchers showed that a…
Dr. Supriya Chopra and Dr. Remi Nout on BIOEMBRACE
A mathematical puzzle fascinated Susan Ellenberg as a child. John is twice Mary’s age when John was Mary’s age. When Mary will be John’s age,…
Hear Alan P. Venook, MD, discuss recent updates to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for gastrointestinal cancers.
Jairam Krishnamurthy, MD, FACP, discusses the selective use of CDK4/6 inhibitors after prior progression on these agents in patients with breast cancer.
An abstract is unavailable.
Panelists discuss how they balance efficacy outcomes like overall survival and progression-free survival against tolerability and quality of life considerations when making decisions about first-line…
WorldScribe: Towards Context-Aware Live Visual DescriptionsRuei-Che Chang, Yuxuan Liu, Anhong GuoUIST 2024: The ACM Symposium on User Interface Software and …
The incorporation of zolbetuximab in addition to chemotherapy has shown benefit in patients with Claudin 18.2–positive gastric cancers in clinical trials.